No it won't - its some level of initial support but real support is where the moving averages converge in the low mid 10's. It's really dependent on how well biotechs and the market are trading unless there's a major data release to push it up.
I am seeing a lot of weakness in bios and the pops are mostly dead cat bounces on previous pumps.
Might be worth buying for a boucne if you really beleive it will be defended, keep a stop under 10.30 though unless its an investment rather then a boucne off support trade.
Market Data 
Markets 
AI
